, professor in 91ÑÇɫ’s School of Health Policy & Management in the Faculty of Health, spoke to BNN on April 14 about the Ontario government’s latest plan to reduce the cost of generic drugs and whether the plan should benefit drug manufacturers, pharmacies, or people paying for drug prescriptions.
Lexchin, has worked as an emergency physician at the since 1988. His research interests include: physician prescribing behaviour, pharmaceutical promotion and the drug approval process. He has been a consultant on pharmaceutical issues to the Ontario government, the federal Auditor General, the government of New Zealand, the Australian National Prescribing Service, and the .
The interview runs approximately nine minutes and is .
Lexchin was also interviewed by CBC's .
Posted by Elizabeth Monier-Williams, with files courtesy of YFile– 91ÑÇɫ’s daily e-bulletin.